Nicotinic acetylcholine receptors play a role in THC dependence, with human genetic confirmation
Specific nicotinic receptor subtypes (alpha3beta4 and alpha6beta4) modulated THC withdrawal in mice, and genetic variations in these same receptor genes were associated with cannabis disorder in humans.
Quick Facts
What This Study Found
Alpha3beta4 nAChR antagonist/partial agonist reduced THC withdrawal signs. Alpha5 and alpha6 nAChR knockout mice had decreased withdrawal. Beta2 and alpha7 knockouts showed no change. Human genetic association studies confirmed that variations in genes coding for alpha5, alpha3, beta4, and alpha6 nAChRs were associated with cannabis disorder phenotypes.
Key Numbers
AuIB (alpha3beta4 antagonist) and AT-1001 (alpha3beta4 partial agonist) dose-dependently attenuated THC withdrawal. Alpha5 and alpha6 KO mice: decreased withdrawal. Beta2, alpha7 KO: no change. Human genes: CHRNA5, CHRNA3, CHRNB4, CHRNA6 associated with cannabis disorder.
How They Did This
Multi-approach study: pharmacological challenges in THC-dependent mice, knockout mouse models (alpha5, alpha6, beta2, alpha7 nAChRs), and human genetic association studies for cannabis disorder phenotypes.
Why This Research Matters
This identifies specific nicotinic receptor subtypes as potential medication targets for cannabis dependence, supported by converging evidence from animal pharmacology, knockout genetics, and human genomics.
The Bigger Picture
The nicotinic-cannabinoid system interaction provides a novel therapeutic target class for cannabis dependence, leveraging existing knowledge from nicotine addiction pharmacology.
What This Study Doesn't Tell Us
Animal withdrawal model uses rimonabant-precipitated withdrawal which may not fully match human spontaneous withdrawal; human genetic associations are correlational; specific mechanism of nicotinic-cannabinoid interaction not fully elucidated.
Questions This Raises
- ?Could existing nicotinic receptor drugs (like varenicline) help with cannabis cessation?
- ?Would alpha3beta4 partial agonists be effective and tolerable in human cannabis dependence?
Trust & Context
- Key Stat:
- Mouse pharmacology, knockout genetics, and human genomics converged on the same nicotinic receptor subtypes
- Evidence Grade:
- Strong converging evidence from three complementary approaches (pharmacology, knockout mice, human genetics).
- Study Age:
- Published in 2020.
- Original Title:
- Neuronal nicotinic acetylcholine receptors mediate ∆9 -THC dependence: Mouse and human studies.
- Published In:
- Addiction biology, 25(1), e12691 (2020)
- Authors:
- Donvito, Giulia(2), Muldoon, Pretal P(4), Jackson, Kia J, Ahmad, Urslan, Zaveri, Nur T, McIntosh, J Michael, Chen, Xiangning, Lichtman, Aron H, Damaj, M Imad
- Database ID:
- RTHC-02519
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What do nicotine receptors have to do with cannabis addiction?
This study found that specific nicotinic acetylcholine receptor subtypes modulate THC withdrawal. This means the brain systems involved in nicotine and cannabis dependence overlap, and drugs targeting nicotinic receptors could potentially help with cannabis cessation.
Could this lead to new treatments?
Yes. The convergence of animal and human genetic evidence on specific receptor subtypes (alpha3beta4, alpha6beta4) provides clear targets for medication development. Some existing nicotinic receptor drugs could be candidates for repurposing.
Read More on RethinkTHC
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-use-disorder-test
- cross-addiction-quit-weed-start-drinking
- is-weed-addictive
- is-weed-addictive-science
- quitting-weed-and-alcohol
- rehab-for-weed-addiction-necessary
- signs-of-cannabis-use-disorder
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-02519APA
Donvito, Giulia; Muldoon, Pretal P; Jackson, Kia J; Ahmad, Urslan; Zaveri, Nur T; McIntosh, J Michael; Chen, Xiangning; Lichtman, Aron H; Damaj, M Imad. (2020). Neuronal nicotinic acetylcholine receptors mediate ∆9 -THC dependence: Mouse and human studies.. Addiction biology, 25(1), e12691. https://doi.org/10.1111/adb.12691
MLA
Donvito, Giulia, et al. "Neuronal nicotinic acetylcholine receptors mediate ∆9 -THC dependence: Mouse and human studies.." Addiction biology, 2020. https://doi.org/10.1111/adb.12691
RethinkTHC
RethinkTHC Research Database. "Neuronal nicotinic acetylcholine receptors mediate ∆9 -THC d..." RTHC-02519. Retrieved from https://rethinkthc.com/research/donvito-2020-neuronal-nicotinic-acetylcholine-receptors
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.